Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
暂无分享,去创建一个
Peter A C 't Hoen | Alexander E. Ivliev | A. Ivliev | M. Sergeeva | Alexander E Ivliev | Marina G Sergeeva | P. ’. ’t Hoen
[1] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[2] S. Nelson,et al. DNA-microarray analysis of brain cancer: molecular classification for therapy , 2004, Nature Reviews Neuroscience.
[3] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[4] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[5] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[6] Jean-Yves Delattre,et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile , 2008, Molecular Cancer.
[7] S. Horvath,et al. Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks , 2006, BMC Genomics.
[8] Jonathan D. Licht,et al. Mammalian Sprouty Proteins Inhibit Cell Growth and Differentiation by Preventing Ras Activation* , 2001, The Journal of Biological Chemistry.
[9] Wenjun Guo,et al. Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.
[10] D. Botstein,et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Horvath,et al. Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.
[12] S. Horvath,et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.
[13] Bin Zhang,et al. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..
[14] S. Horvath,et al. A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.
[15] N. Hacohen,et al. sprouty Encodes a Novel Antagonist of FGF Signaling that Patterns Apical Branching of the Drosophila Airways , 1998, Cell.
[16] D. Bar-Sagi,et al. The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Raymond,et al. Lessons learned in the development of targeted therapy for malignant gliomas , 2007, Molecular Cancer Therapeutics.
[18] Yu Liang,et al. Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas , 2005, BMC clinical pathology.
[19] A. Chinnaiyan,et al. Integrative analysis of the cancer transcriptome , 2005, Nature Genetics.
[20] A. Iafrate,et al. Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2 , 2006, Journal of neuropathology and experimental neurology.
[21] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[22] R. Salgia,et al. Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas , 2006, Clinical Cancer Research.
[23] T. Golub,et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.
[24] Eytan Domany,et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. , 2003, Cancer research.
[25] David E. Misek,et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. , 2003, The American journal of pathology.
[26] Kai Wang,et al. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks , 2007, ISMB/ECCB.
[27] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[28] Tom C. Freeman,et al. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data , 2008, Molecular Cancer Therapeutics.
[29] Lei Liu,et al. A study of inter-lab and inter-platform agreement of DNA microarray data , 2005, BMC Genomics.
[30] P. Brown,et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[32] D. Louis,et al. Glioma classification: a molecular reappraisal. , 2001, The American journal of pathology.
[33] Hiroyuki Aburatani,et al. Selective Expression of a Subset of Neuronal Genes in Oligodendroglioma with Chromosome 1p Loss , 2004, Brain pathology.
[34] Jun Dong,et al. Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..
[35] S. Horvath,et al. Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.
[36] E. Domany,et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] Boon Chuan Low,et al. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling , 2002, The EMBO journal.
[39] Yuri Kotliarov,et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. , 2009, Cancer research.
[40] C. Der,et al. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.
[41] Andrew P. Stubbs,et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. , 2009, Cancer research.
[42] ZhangBin,et al. Defining clusters from a hierarchical cluster tree , 2008 .
[43] Z. Kohutek,et al. ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-α Dependent and Promotes Glioblastoma Cell Migration , 2009, The Journal of Neuroscience.
[44] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.